Metastasis of nasopharyngeal carcinoma (NPC) remains a main cause of death for NPC
patients even though great advances have been made in therapeutic approaches. An in …

Radiotherapy is the primary treatment for patients with nasopharyngeal carcinoma (NPC),
and approximately 20% of patients experience treatment failure due to tumour …

Nasopharyngeal cancer (NPC) has a unique histopathology compared with other head and
neck cancers. Individual NPC patients may attain different outcomes. This study aims to …

Head and neck cancer (HNC) is a heterogenous and complex entity including diverse
anatomical sites and a variety of tumor types displaying unique characteristics and different …

Abstract Purpose: Epstein–Barr virus (EBV) is associated with several cancers in which the
tumor cells express EBV antigens EBNA1 and LMP2. A therapeutic vaccine comprising a …

Epstein–Barr virus (EBV) is implicated as an aetiological factor in B lymphomas and
nasopharyngeal carcinoma. The mechanisms of cell-free EBV infection of nasopharyngeal …

Epstein–Barr virus (EBV) is associated with several malignancies including nasopharyngeal
carcinoma, a high incidence tumor in Chinese populations, in which tumor cells express the …

Purpose To investigate the prognostic performance of radiomics features, as extracted from
positron emission tomography (PET) and X-ray computed tomography (CT) components of …

Objective: Nasopharyngeal cancer is one of the most common cancers in the head and neck
areas. Men are two to three times more likely to develop it than women. The peak age of …

Background: Bactericidal/Permeability-increasing-fold-containing family B member 1
(BPIFB1, previously termed LPLUNC1) is highly expressed in the nasopharynx, significantly …